| Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer JL Tanyi, S Bobisse, E Ophir, S Tuyaerts, A Roberti, R Genolet, ... Science translational medicine 10 (436), eaao5931, 2018 | 431 | 2018 |
| Hypochlorous acid: a natural adjuvant that facilitates antigen processing, cross-priming, and the induction of adaptive immunity ZM Prokopowicz, F Arce, R Biedron, CLL Chiang, M Ciszek, DR Katz, ... The journal of immunology 184 (2), 824-835, 2010 | 329 | 2010 |
| Whole tumor antigen vaccines: where are we? CLL Chiang, G Coukos, LE Kandalaft Vaccines 3 (2), 344-372, 2015 | 287 | 2015 |
| Whole tumor antigen vaccines CLL Chiang, F Benencia, G Coukos Seminars in immunology 22 (3), 132-143, 2010 | 270 | 2010 |
| A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedside CLL Chiang, LE Kandalaft, J Tanyi, AR Hagemann, GT Motz, N Svoronos, ... Clinical cancer research 19 (17), 4801-4815, 2013 | 248 | 2013 |
| Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo co-stimulated T cells in recurrent ovarian cancer LE Kandalaft, DJ Powell, Jr, CL Chiang, J Tanyi, S Kim, M Bosch, ... Oncoimmunology 2 (1), e22664, 2013 | 184 | 2013 |
| Adjuvants for enhancing the immunogenicity of whole tumor cell vaccines CLL Chiang, LE Kandalaft, G Coukos International reviews of immunology 30 (2-3), 150-182, 2011 | 141 | 2011 |
| A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer LE Kandalaft, CL Chiang, J Tanyi, G Motz, K Balint, R Mick, G Coukos Journal of translational medicine 11, 1-14, 2013 | 105 | 2013 |
| Hypochlorous acid enhances immunogenicity and uptake of allogeneic ovarian tumor cells by dendritic cells to cross-prime tumor-specific T cells CLL Chiang, JA Ledermann, AN Rad, DR Katz, BM Chain Cancer Immunology, Immunotherapy 55, 1384-1395, 2006 | 81 | 2006 |
| Oxidation of ovarian epithelial cancer cells by hypochlorous acid enhances immunogenicity and stimulates T cells that recognize autologous primary tumor CLL Chiang, JA Ledermann, E Aitkens, E Benjamin, DR Katz, BM Chain Clinical Cancer Research 14 (15), 4898-4907, 2008 | 79 | 2008 |
| Cryoablation and immunotherapy: an enthralling synergy to confront the tumors C Yakkala, CLL Chiang, L Kandalaft, A Denys, R Duran Frontiers in immunology 10, 2283, 2019 | 77 | 2019 |
| Day-4 myeloid dendritic cells pulsed with whole tumor lysate are highly immunogenic and elicit potent anti-tumor responses CLL Chiang, AR Hagemann, R Leskowitz, R Mick, T Garrabrant, ... PloS one 6 (12), e28732, 2011 | 67 | 2011 |
| The current clinical landscape of personalized cancer vaccines H Fritah, R Rovelli, CLL Chiang, LE Kandalaft Cancer Treatment Reviews 106, 102383, 2022 | 55 | 2022 |
| The differential influence of allogeneic tumor cell death via DNA damage on dendritic cell maturation and antigen presentation AN Rad, G Pollara, SMA Sohaib, C Chiang, BM Chain, DR Katz Cancer research 63 (16), 5143-5150, 2003 | 53 | 2003 |
| Optimizing parameters for clinical-scale production of high IL-12 secreting dendritic cells pulsed with oxidized whole tumor cell lysate CLL Chiang, DA Maier, LE Kandalaft, AL Brennan, E Lanitis, Q Ye, ... Journal of Translational Medicine 9, 1-16, 2011 | 46 | 2011 |
| In vivo cancer vaccination: Which dendritic cells to target and how? CLL Chiang, LE Kandalaft Cancer treatment reviews 71, 88-101, 2018 | 45 | 2018 |
| Potential approaches for more successful dendritic cell-based immunotherapy CLL Chiang, K Balint, G Coukos, LE Kandalaft Expert opinion on biological therapy 15 (4), 569-582, 2015 | 45 | 2015 |
| Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancer JL Tanyi, CLL Chiang, J Chiffelle, AC Thierry, P Baumgartener, F Huber, ... npj Vaccines 6 (1), 36, 2021 | 42 | 2021 |
| Rapid tumor vaccine using Toll-like receptor-activated ovarian cancer ascites monocytes SF Adams, AJ Grimm, CLL Chiang, A Mookerjee, D Flies, S Jean, ... Journal for immunotherapy of cancer 8 (2), 2020 | 27 | 2020 |
| Are dendritic cells the most appropriate therapeutic vaccine for patients with ovarian cancer? S Martin-Lluesma, M Graciotti, AJ Grimm, C Boudousquié, CL Chiang, ... Current opinion in biotechnology 65, 190-196, 2020 | 16 | 2020 |
